Silver Coast Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-10,081
Closed -$547K – 94
2024
Q1
$547K Buy
10,081
+496
+5% +$25.3K 0.22% 34
2023
Q4
$492K Buy
+9,585
New +$503K 0.22% 29

Other funds holding BMY

Silver Coast Investments's BMY Position: Q2 2024 in Review

Silver Coast Investments sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 10,081 shares — an estimated $547K sold.

Silver Coast Investments first reported a position in BMY in Q4 2023 and held it in 2 quarters. The position peaked at $547K in Q1 2024. 2,154 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Silver Coast Investments reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Silver Coast Investments sold 10,081 Bristol-Myers Squibb shares in Q2 2024, an estimated $547K.
  • Silver Coast Investments first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 2 quarters.
  • Silver Coast Investments's Bristol-Myers Squibb position peaked at $547K in Q1 2024.
  • 2,154 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Silver Coast Investments's 13F filing for Q2 2024, filed 9 Aug 2024.